Clinical Trial Update: Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and safety of a grass pollen sublingual tablet in adults with allergic rhinitis with conjunctivitis; results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• GRAZAX (birch pollen sublingual immunotherapy tablet)

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Rhinoconjunctivitis, Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2012-09-07